Quinazoline derivatives for the treatement of abnormal cell growth

Details for Australian Patent Application No. 2002339687 (hide)

Owner PFIZER PRODUCTS INC.

Inventors Moyer, James Dale; Connell, Richard Damian; Kath, John Charles

Agent Shelston IP

Pub. Number AU-A-2002339687

PCT Number PCT/IB02/04636

PCT Pub. Number WO2003/049740

Priority 60/341,091 12.12.01 US

Filing date 4 November 2002

Wipo publication date 23 June 2003

International Classifications

A61K 031/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

A61P 035/00 Antineoplastic agents

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 60/341,091 12.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002339687

4 May 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002339688-GLUCOSET AGONISTS AND ANTAGONISTS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS

2002339686-NGZIPA, NGZIPD, PGZIPA, and PGZIPD polynucleotides and polypeptides and uses thereof